Berg

06/06/2022

Every year during the month of June, the Le***an, Gay, Bisexual, Transgender, Q***r, Intersex, Asexual (LGBTQIA+) community celebrates Pride Month. This month serves to recognize the influence the LGBTQIA+ community has had across the globe. This month was chosen because of the Stonewall Riots in 1969, Greenwich Village, New York City, NY.

Pride Month is to commemorate a tipping point in our history and to bring about awareness of the LGBTQIA+ community and the diversity we have in one another. It is important to recognize the accomplishments of the gay rights movement and how much has been accomplished in their fight for equality. Pride also serves as a reminder of the importance of diversity and inclusion, the joy and power of recognizing the full value of everyone, and the battle for acceptance and inclusion.

BERG recognizes and supports diversity in the workplace and if you ever have questions or concerns please refer to the resources and links provided below. We know - navigating being LGBTQIA+ in science can be very difficult.

• LGBTQ Resource List: https://www.glaad.org/resourcelist
• Trevor Project Lifeline: (800) 788-7386
The Trevor Lifeline provides support to LGBTQ youths and allies in crisis or in need of a safe and judgment-free place to talk.
• Trans Lifeline: (877) 565-8860
Trans Lifeline provides peer support for the transgender community and is run by and for trans people.
• SAGE National LGBT Elder Hotline: (877) 360-LGBT (5428)
The SAGE Hotline connect LGBT older people and their caregivers with friendly responders who are ready to listen.
• National Su***de Prevention Lifeline for LGBTQ+ Community: (800) 273-8255
This page offers information and resources for LGBTQ+ individuals who are struggling with suicidal feelings or mental health crises.
• LGBT National Help Center
A national resource that provides LGBTQ+ community with free & confidential support and referral resources via phone, text, and chat.
• Colors Youth
This non-profit organization provides free and unlimited mental health services for LGBTQ-identified youths ages 25 and younger.
• National Alliance on Mental Illness (NAMI) LGBTQI Page
This page highlights the unique mental health needs of the LGBTQ+ community and includes hotlines and resources to help address those needs.

05/06/2020

Each year, millions of Americans are impacted and diagnosed with inflammatory diseases. This morning, we announced a new partnership with Boehringer Ingelheim which will leverage their and expertise with our . Our combined efforts will help patients who suffer from , including (IBD), by identifying biomarkers that can transform current tactics and treatments. Read more in our live announcement: https://www.prnewswire.com/news-releases/berg-presents-initial-clinical-data-and-identification-of-response-biomarkers-in-a-phase-2-pancreatic-cancer-trial-guided-by-using-the-interrogative-biology-platform-at-asco-gi-meeting-300993149.html

/PRNewswire/ -- BERG, a biopharmaceutical company that merges biology with technology to map and identify drivers of diseases, today announced the presentation...

04/13/2020

has been named a in Frost & Sullivan’s first-ever Frost Radar in report in the Pharmaceutical Industry. BERG was selected from 50 global companies for its unique use of AI and biology as well as the strength of our partnerships.

/PRNewswire/ -- BERG, a clinical-stage biotech company that uses artificial intelligence (AI) to research diseases and develop innovative treatments, has been...

03/12/2020

Digital Trends had BERG CEO Niven Narain as a guest last Thursday where Niven shared his insights on the convergence of AI and biology to enhance drug discovery and development pipelines. Don't miss this great interview!

On this Digital Trends Live, we discuss trending tech stories including Netflix and Apple backing out of SXSW, Twitter’s “Fleets,” and Stadia finally goes 4K.

03/09/2020

Last Thursday, BERG CEO Niven Narain was a guest of where he discussed the intersection of AI and biology as a viable solution in enhancing drug discovery and development to help save patient lives. You can watch his interview on the Episode 330 recap:

On this Digital Trends Live, we discuss trending tech stories including Netflix and Apple backing out of SXSW, Twitter’s “Fleets,” and Stadia finally goes 4K.

03/06/2020

BERG CEO Niven Narain spoke with Robert Reiss, Forbes contributor and radio host of The CEO Forum, regarding the convergence of AI and drug development. Check out the live piece -

Often acknowledged as a game-changing technology, AI offers untapped potential in improving established ways of doing business, as well as with new opportunities in meeting and addressing critical pain points across many industries, including banking, manufacturing and healthcare.

03/05/2020

BERG's CEO, Niven R. Narain, recently spoke to Robert Reiss, Founder and CEO, The CEO Forum Group where he discussed BERG’s initiatives with AI, Biology and our approach to efficiently advancing therapeutics into human trials. The summary of Dr. Narain’s discussion with Mr. Reiss is featured on Forbes.com titled “Transforming Drug Discovery Through Artificial Intelligence”. The article highlights BERG’s focus on a patient-first approach to drug development, using AI to merge biology and technology to map human disease.

The article describes the AI-powered development efforts of BPM 31510 in oncology, specifically in aggressive cancers that was informed by leveraging comprehensive multi-omic capture of patient biology. BERG’s platform is disease agnostic and is focused on understanding the biological basis of disease with a goal to transform the future of healthcare by creating more precision and predictability in the process of advancing drugs to the market.

https://www.forbes.com/sites/robertreiss/2020/03/03/transforming-drug-discovery-through-artificial-intelligence/

Often acknowledged as a game-changing technology, AI offers untapped potential in improving established ways of doing business, as well as with new opportunities in meeting and addressing critical pain points across many industries, including banking, manufacturing and healthcare.

02/29/2020

BERG is passionate and committed to making a difference in the lives of patients who suffer from and their families. On this Rare Disease Day, BERG would like to thank the patients, their families and care-givers for support of BERG’s commitment to improve lives of patients with Epidermolysis Bullosa (EB). BERG’s mission is dedicated to mapping the molecular cause of disease through the use of Interrogative Biology platform to identify targets, enable novel drug discovery and improve outcomes in all disease. Learn more about us and our mission at https://www.berghealth.com/about/

https://www.rarediseaseday.org/

BERG is a clinical-stage, artificial intelligence-powered biotech leveraging its proprietary platform, Interrogative Biology®, to map disease and revolutionize treatments across oncology, neurology and rare diseases. By taking a Back to Biology™ approach, BERG is able to identify critical biomark...

02/17/2020

Employee Event: Pre-Superbowl Gathering & Chili Cook-off

On Friday, January 31, 2020, we enjoyed the culinary talents of our employees. Several of our employees brought in chili, hot dips, and baked goods. Great way to start the weekend festivities of the Superbowl.

01/29/2020

At ASCO-GI, BERG presented initial results via the BERG Interrogative Biology Platform for a Phase 2 clinical trial of a pancreatic cancer drug. Learn more in our live press release

/PRNewswire/ -- BERG, a biopharmaceutical company that merges biology with technology to map and identify drivers of diseases, today announced the presentation...

01/27/2020

BERG CEO Niven Narain spoke with Financial Times' global pharma editor Sarah Neville on 2020 as the year of actualizing AI's impact on drug development. See his thoughts in Financial Times' Why Big Pharma See a Remedy in Data and AI -

Billions are being invested into mining patient records in a bid to aid drug discovery but backers are impatient